People: Oncolytics Biotech Inc (ONCY.O)
2.95USD
4:00pm EST
$0.33 (+12.60%)
$2.62
$2.95
$3.09
$2.70
1,069,134
155,962
$3.80
$1.14
Thompson, Bradley
Brief Biography
Dr. Bradley G. Thompson is Executive Chairman of the Board, President and Chief Executive Officer of Oncolytics Biotech, Inc., since April 1999.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 444,996 | -- | 46,700 | 491,696 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | 786,160 | -- |
| Unexercisable | -- | -- |
| Excercised | 284,000 | 618,960.00 |
| Name | Fiscal Year Total |
|---|---|
| Thompson, Bradley | 491,696 |
| Ball, Douglas | 293,021 |
| Coffey, Matthew | 365,817 |
| Gill, George | 135,314 |
| Warrander, Alan | -- |
| Dillahunty, Mary | 262,957 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
